METTL3 and metabolic dysfunction-associated steatotic liver disease: NAFLD liver samples had increased METTL3, METTL15, FTO, and EIF3H (an m6A writer) expression, while WTAP, RBM15, YTHDC1, YTHDC2, IGF2BP2, HNRNPC, and HNRNPA2B1 expression was decreased [171].